AK Medical Holdings Yönetim
Yönetim kriter kontrolleri 4/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Zhijiang Li
İcra Kurulu Başkanı
CN¥1.1m
Toplam tazminat
| CEO maaş yüzdesi | 74.9% |
| CEO görev süresi | 9.3yrs |
| CEO sahipliği | 45.0% |
| Yönetim ortalama görev süresi | 3.9yrs |
| Yönetim Kurulu ortalama görev süresi | 8.8yrs |
Son yönetim güncellemeleri
Recent updates
AK Medical Holdings Limited's (HKG:1789) Intrinsic Value Is Potentially 92% Above Its Share Price
Aug 30
Why We're Not Concerned Yet About AK Medical Holdings Limited's (HKG:1789) 25% Share Price Plunge
Jun 20It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year
Jun 11Returns On Capital At AK Medical Holdings (HKG:1789) Paint A Concerning Picture
May 27We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt
May 08Investors Appear Satisfied With AK Medical Holdings Limited's (HKG:1789) Prospects
Apr 21AK Medical Holdings Limited (HKG:1789) Analysts Are Reducing Their Forecasts For This Year
Apr 01AK Medical Holdings' (HKG:1789) Returns On Capital Not Reflecting Well On The Business
Jan 22Shareholders Should Be Pleased With AK Medical Holdings Limited's (HKG:1789) Price
Jan 04AK Medical Holdings (HKG:1789) Seems To Use Debt Rather Sparingly
Dec 12A Look At The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Nov 09AK Medical Holdings (HKG:1789) Could Be Struggling To Allocate Capital
Sep 20AK Medical Holdings (HKG:1789) Could Easily Take On More Debt
Sep 03Investors Could Be Concerned With AK Medical Holdings' (HKG:1789) Returns On Capital
Jun 07Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
May 18Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Feb 13Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Nov 10Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Sep 29Be Wary Of AK Medical Holdings (HKG:1789) And Its Returns On Capital
Aug 04Are Investors Undervaluing AK Medical Holdings Limited (HKG:1789) By 44%?
Jun 25There Are Reasons To Feel Uneasy About AK Medical Holdings' (HKG:1789) Returns On Capital
Apr 11Capital Allocation Trends At AK Medical Holdings (HKG:1789) Aren't Ideal
Oct 08Estimating The Intrinsic Value Of AK Medical Holdings Limited (HKG:1789)
Sep 20Analysts Are More Bearish On AK Medical Holdings Limited (HKG:1789) Than They Used To Be
Jul 27I Built A List Of Growing Companies And AK Medical Holdings (HKG:1789) Made The Cut
Jul 19AK Medical Holdings Limited (HKG:1789) Shares Could Be 39% Below Their Intrinsic Value Estimate
Jun 16The Returns On Capital At AK Medical Holdings (HKG:1789) Don't Inspire Confidence
Jun 01AK Medical Holdings Limited (HKG:1789) Analysts Are More Bearish Than They Used To Be
Apr 01CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥189m |
| Mar 31 2024 | n/a | n/a | CN¥185m |
| Dec 31 2023 | CN¥1m | CN¥814k | CN¥182m |
| Sep 30 2023 | n/a | n/a | CN¥197m |
| Jun 30 2023 | n/a | n/a | CN¥211m |
| Mar 31 2023 | n/a | n/a | CN¥208m |
| Dec 31 2022 | CN¥972k | CN¥806k | CN¥205m |
| Sep 30 2022 | n/a | n/a | CN¥156m |
| Jun 30 2022 | n/a | n/a | CN¥107m |
| Mar 31 2022 | n/a | n/a | CN¥100m |
| Dec 31 2021 | CN¥913k | CN¥800k | CN¥93m |
| Sep 30 2021 | n/a | n/a | CN¥178m |
| Jun 30 2021 | n/a | n/a | CN¥263m |
| Mar 31 2021 | n/a | n/a | CN¥288m |
| Dec 31 2020 | CN¥524k | CN¥430k | CN¥314m |
| Sep 30 2020 | n/a | n/a | CN¥307m |
| Jun 30 2020 | n/a | n/a | CN¥300m |
| Mar 31 2020 | n/a | n/a | CN¥284m |
| Dec 31 2019 | CN¥1m | CN¥779k | CN¥267m |
| Sep 30 2019 | n/a | n/a | CN¥235m |
| Jun 30 2019 | n/a | n/a | CN¥203m |
| Mar 31 2019 | n/a | n/a | CN¥174m |
| Dec 31 2018 | CN¥1m | CN¥764k | CN¥145m |
| Sep 30 2018 | n/a | n/a | CN¥136m |
| Jun 30 2018 | n/a | n/a | CN¥127m |
| Mar 31 2018 | n/a | n/a | CN¥116m |
| Dec 31 2017 | CN¥776k | CN¥765k | CN¥105m |
Tazminat ve Piyasa: Zhijiang 'nin toplam tazminatı ($USD 152.64K ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 495.13K ).
Tazminat ve Kazançlar: Zhijiang 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Zhijiang Li (56 yo)
9.3yrs
Görev süresi
CN¥1,087,000
Tazminat
Mr. Zhijiang Li serves as Chairman and Chief Executive Officer at AK Medical Holdings Limited. Mr. Li is responsible for the overall strategic planning and development of at AK Medical Holdings Limited. Mr...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & CEO | no data | CN¥1.09m | 45% HK$ 2.4b | |
| Senior VP & Executive Director | 8.6yrs | CN¥193.00k | 0.90% HK$ 47.8m | |
| Senior VP & Executive Director | 8.6yrs | CN¥1.19m | 5.24% HK$ 277.6m | |
| Executive Director | no data | CN¥1.57m | 0.19% HK$ 10.1m | |
| Chief Financial Officer | 3.9yrs | Veri yok | Veri yok | |
| Vice President of Human Resources | 3.5yrs | Veri yok | Veri yok | |
| Company Secretary | less than a year | Veri yok | Veri yok |
3.9yrs
Ortalama Görev Süresi
53yo
Ortalama Yaş
Deneyimli Yönetim: 1789 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.9 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & CEO | 9.3yrs | CN¥1.09m | 45% HK$ 2.4b | |
| Senior VP & Executive Director | 9.3yrs | CN¥193.00k | 0.90% HK$ 47.8m | |
| Senior VP & Executive Director | 9.3yrs | CN¥1.19m | 5.24% HK$ 277.6m | |
| Executive Director | 8.8yrs | CN¥1.57m | 0.19% HK$ 10.1m | |
| Non-Executive Director | 8.8yrs | Veri yok | Veri yok | |
| Independent Non-Executive Director | 7yrs | CN¥178.00k | Veri yok | |
| Independent Non-Executive Director | 7yrs | CN¥178.00k | Veri yok | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok |
8.8yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 1789 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.8 yıldır).